ECL

Ecolab Inc.

$274.12 -8.96 (-3.17%) At close · Jul 8

Market Cap

$76.84B

281,437,502

Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.

Revenue

$16.08B +2.2%

FY2025

Net Income

$2.08B -1.7%

FY2025

Gross Margin

44.46% +1pp

FY2025

Operating Margin

17.02% -0.8pp

FY2025

Diluted EPS

$7.28 -1.2%

FY2025

Operating Cash Flow

$2.95B +4.9%

FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics

Annual Quarterly

Line Item	3Y	5Y	10Y	FY2026 (G)	TTM	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013	FY2012	FY2011	FY2010	FY2009	FY2008	FY2007
Revenue	+4.3%	+6.4%	+1.7%	—	$16.45B	$16.08B	$15.74B	$15.32B	$14.19B	$12.73B	$11.79B	$12.56B	$12.22B	$13.84B	$13.15B	$13.55B	$14.28B	$13.25B	$11.84B	$6.8B	$6.09B	$5.9B	$6.14B	$5.47B
Rental Income	+6.4%	+9.5%	—	—	$574.3M	$562.1M	$534.9M	$511.8M	$466.7M	$412.5M	$356.3M	$412.7M	—	—	—	—	—	—	—	—	—	—	—	—
Cost of Revenue	+0.4%	+5.3%	+2.1%	—	$9.17B	$8.93B	$8.9B	$9.15B	$8.83B	$7.62B	$6.91B	$7.05B	$6.88B	$8.06B	$7.53B	$7.22B	$7.68B	$7.16B	$6.39B	$3.48B	$3.01B	$2.98B	$3.14B	$2.69B
Gross Profit	+10.1%	+7.9%	+1.2%	—	$7.29B	$7.15B	$6.84B	$6.17B	$5.36B	$5.12B	$4.88B	$5.52B	$5.35B	$5.77B	$5.62B	$6.32B	$6.6B	$6.09B	$5.45B	$3.32B	$3.08B	$2.92B	$3B	$2.78B
Gross Margin	—	—	—	—	—	44.46%	43.46%	40.24%	37.76%	40.19%	41.43%	43.91%	43.75%	41.72%	42.72%	46.67%	46.23%	45.97%	46.06%	48.88%	50.51%	49.53%	48.81%	50.79%
Research & Development	+2.1%	+1.8%	+0.6%	—	—	$202M	$207M	$192M	$190M	$186M	$185M	$190M	$193M	$201M	$189M	$191M	$197M	$188M	$183M	$96M	$88M	$86M	$86M	—
Selling, General & Administrative	+5.2%	+5.2%	-0.2%	—	$4.31B	$4.26B	$4.23B	$4.06B	$3.65B	$3.42B	$3.31B	$3.55B	$3.51B	$3.83B	$3.71B	$4.35B	$4.58B	$4.36B	$4.02B	$2.44B	$2.26B	$2.17B	$2.26B	$2.09B
Amortization of Intangibles	-1.7%	+6.8%	+0.4%	—	$311.7M	$304M	$301M	$307M	$320M	$239M	$219M	$206M	$193M	$308M	$290M	$292M	$305M	$293M	$237M	$62M	$41M	—	—	—
Depreciation & Amortization	+28.8%	+19.6%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	$714.5M	$395.7M	$347.9M	$334.3M	$334.7M	$291.9M
Restructuring Charges	-55.6%	—	—	—	—	—	—	—	$9.9M	$5.3M	$41.8M	$113M	$84.4M	—	—	—	—	—	—	—	—	$72.5M	—	—
Operating Income	+20.6%	+14.4%	+5.8%	—	$2.8B	$2.74B	$2.8B	$1.99B	$1.56B	$1.6B	$1.4B	$1.85B	$1.73B	$1.95B	$1.87B	$1.56B	$1.96B	$1.56B	$1.29B	$753.8M	$806.8M	$681.3M	$712.8M	$669M
Operating Margin	—	—	—	—	—	17.02%	17.8%	13%	11.01%	12.55%	11.84%	14.69%	14.14%	14.09%	14.22%	11.53%	13.69%	11.78%	10.89%	11.09%	13.25%	11.55%	11.61%	12.23%
EBITDA	+25.4%	+15.8%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	$2B	$1.15B	$1.15B	$1.02B	$1.05B	$960.9M
Interest Expense	+6.7%	+0.1%	+1.9%	—	$310.9M	$306.2M	$340.3M	$348.9M	$252.1M	$230.6M	$304.8M	$214.4M	$235.5M	$274.6M	$285.4M	$253.7M	$268M	$272.8M	$285.6M	$82.1M	$65.6M	$67.5M	$70.8M	—
Interest Income	+97.1%	+34.8%	+20.5%	—	$55.4M	$65.1M	$57.8M	$52.2M	$8.5M	$12.3M	$14.6M	$23.7M	$14.4M	$19.6M	$20.8M	$10.1M	$11.4M	$10.5M	$8.9M	$7.9M	$6.5M	$6.3M	$9.2M	—
Other Non-Operating Income	+28.0%	-1.7%	—	—	$47.2M	$51.4M	$51.3M	$59.9M	$24.5M	$33.9M	$55.9M	$77M	$79.9M	$67.3M	$43.8M	—	—	—	—	—	—	—	—	—
Pretax Income	+23.8%	+17.0%	+6.8%	—	$2.6B	$2.55B	$2.57B	$1.76B	$1.34B	$1.41B	$1.16B	$1.73B	$1.59B	$1.76B	$1.65B	$1.32B	$1.7B	$1.3B	$1.01B	$679.6M	$747.7M	$620.1M	$651.2M	$618M
Income Tax	+24.7%	+20.8%	+4.2%	—	$472.6M	$454.6M	$439.3M	$362.5M	$234.5M	$270.2M	$176.6M	$288.6M	$321.2M	$243.8M	$402.9M	$300.5M	$476.2M	$324.7M	$311.3M	$216.3M	$216.6M	$201.4M	$202.8M	$189.1M
Net Income	+23.9%	—	+7.4%	—	$2.11B	$2.08B	$2.11B	$1.37B	$1.09B	$1.13B	-$1.19B	$1.58B	$1.44B	$1.52B	$1.25B	$1.02B	$1.22B	$973.6M	$701.3M	$463.3M	$530.3M	$417.3M	$448.1M	$427.2M
Net Margin	—	—	—	—	—	12.91%	13.42%	8.96%	7.69%	8.87%	-10.05%	12.55%	11.78%	10.98%	9.48%	7.51%	8.56%	7.35%	5.92%	6.81%	8.71%	7.07%	7.3%	7.81%
Net Income Attributable to Noncontrolling Interests	+1.0%	—	+1.6%	—	$17.7M	$17.7M	$19.5M	$20.7M	$17.2M	$14.1M	—	$17.3M	$11.2M	$14M	$17.5M	$15.1M	$19.4M	$5.8M	-$2.3M	$800K	$800K	$1.4M	$300K	$1.7M
Net Income Available to Common Stockholders	—	-0.8%	+3.6%	—	—	—	—	$1.37B	$1.09B	$1.13B	-$1.21B	$1.56B	$1.43B	$1.5B	$1.23B	$1B	$1.2B	$967.8M	$703.6M	$462.5M	$530.3M	$417.3M	—	—
Comprehensive Income	+29.7%	—	+15.2%	—	$2.54B	$2.18B	$1.98B	$1.25B	$999.9M	$1.49B	-$1.11B	$1.29B	$1.31B	$1.57B	$939.4M	$530.7M	$556.1M	$1.12B	$588.8M	$389.5M	$491.3M	—	—	—
EPS (Basic) USD/shares	+24.2%	—	+8.0%	—	—	$7.33	$7.43	$4.82	$3.83	$3.95	-$4.20	$5.41	$4.95	$5.20	$4.20	$3.38	$4.01	$3.23	$2.41	$1.95	$2.27	$1.76	$1.83	$1.73
EPS (Diluted) USD/shares	+24.1%	—	+8.2%	$8.43 – $8.63*	—	$7.28	$7.37	$4.79	$3.81	$3.91	-$4.15	$5.33	$4.88	$5.12	$4.14	$3.32	$3.93	$3.16	$2.35	$1.91	$2.23	$1.74	$1.80	$1.70
Shares Outstanding (Basic Avg) shares	-0.2%	-0.3%	-0.5%	—	—	283.3M	284.3M	285M	285.2M	286.3M	287M	288.1M	288.6M	289.6M	292.5M	296.4M	300.1M	299.9M	292.5M	236.9M	233.4M	236.7M	245.4M	246.8M
Shares Outstanding (Diluted Avg) shares	-0.2%	-0.4%	-0.6%	—	—	285.2M	286.6M	286.5M	286.6M	289.1M	290.3M	292.5M	292.8M	294M	296.7M	301.4M	305.9M	305.9M	298.9M	242.1M	237.6M	239.9M	249.3M	251.8M

Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2007–FY2025: $8.33B in buybacks, $7.64B in dividends.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue

5.16×

Specialty Chemicals median 3.56×

EV/EBIT

30.25×

Specialty Chemicals median 30.25×

P/E (TTM)

36.95×

Specialty Chemicals median 20.92×

Valuation over time computed as of each quarter's filing date

Revenue Breakdown

Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.

Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.

By Segment (USD)

Component	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31
Water Services	$7,982,400,000	$7,775,900,000	$7,625,500,000	—	—	—	—	—
Global Institutional	$6,104,600,000	$6,103,400,000	$5,910,800,000	$4,432,100,000	$3,966,800,000	$3,553,200,000	$4,401,500,000	$4,302,000,000
Global Pest Elimination	$1,246,300,000	$1,162,800,000	$1,066,000,000	$959,000,000	—	—	—	—
Global Healthcare and Life Sciences	$747,900,000	$699,300,000	$675,400,000	$1,510,500,000	$1,181,600,000	$1,181,900,000	$972,800,000	$939,500,000
Global Industrial	—	$7,777,200,000	$7,626,500,000	$7,197,100,000	$6,237,900,000	$5,870,800,000	$5,980,200,000	$5,806,800,000
Other Reportable Segment	—	—	$1,444,200,000	$1,316,400,000	$1,207,700,000	$1,084,300,000	$1,207,500,000	$1,173,800,000
Corporate	—	—	$42,500,000	$89,100,000	$139,100,000	—	—	—

By Product & Service (USD)

Component	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31
Product and Equipment	$12,618,500,000	$12,473,600,000	$12,316,800,000	$11,446,200,000	$10,153,300,000	$9,466,600,000	$10,129,000,000	$9,903,600,000
Service and Lease	$3,462,700,000	$3,267,800,000	$3,003,400,000	$2,741,600,000	$2,579,800,000	$2,323,600,000	$2,433,000,000	$2,318,500,000

Segment Operating Income

Annual operating income by business segment, as tagged in the company's own XBRL filings. Segments need not sum to the consolidated figure — corporate costs and eliminations are typically unallocated.

By Segment (USD)

Component	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2019-12-31	2018-12-31	2017-12-31
Global Institutional	$1,357,800,000	$1,202,200,000	$856,500,000	$193,400,000	$939,800,000	$1,007,300,000	$962,700,000
Water Services	$1,263,900,000	$1,207,200,000	$1,042,100,000	—	—	—	—
Global Pest Elimination	$237,100,000	$209,700,000	$200,900,000	$948,900,000	—	—	—
Global Healthcare and Life Sciences	$120,700,000	$91,800,000	$118,900,000	$197,300,000	$124,500,000	—	—
Corporate	-$353,200,000	-$12,100,000	-$329,000,000	-$414,300,000	—	—	—
Global Energy	—	—	—	—	$379,100,000	$338,500,000	$322,900,000
Global Industrial	—	$1,182,700,000	$841,800,000	$631,900,000	$902,700,000	$724,400,000	$722,000,000
Other Reportable Segment	—	—	—	—	$167,000,000	$160,000,000	$140,700,000
Upstream Energy	—	—	—	—	$187,900,000	—	—

Operating Margin by Segment (%)

Component	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2019-12-31	2018-12-31
Water Services	15.8%	15.5%	13.7%	—	—	—
Global Institutional	22.2%	19.7%	14.5%	4.4%	21.4%	23.4%
Global Pest Elimination	19%	18%	18.8%	98.9%	—	—
Global Healthcare and Life Sciences	16.1%	13.1%	17.6%	13.1%	12.8%	—
Global Industrial	—	15.2%	11%	8.8%	15.1%	12.5%
Other Reportable Segment	—	—	—	—	13.8%	13.6%
Corporate	—	—	-774.1%	-465%	—	—

Key facts CIK 31462 CUSIP 278865100 13F (30d) 142 filings 102 filers Visit website Investor relations